John V. Heymach, Ross Stewart, David H. Harpole, Tetsuya Mitsudomi, Janis M. Taube, Gabriella Galffy, Gabriel Garbaos, Bivas Biswas, Manuel Domine, Bartomeu Massuti, Thomas Winder, Guzel Mukhametshina, Dinh Van Luong, Jeronimo Rafael Rodriguez Cid, Tamer M. Fouad, Allen Chen, Agrin Moeini Mortazavi, Zhou Zhu, Huiling Xiong, Martin Reck. "Impact of neoadjuvant durvalumab (D) on tumor microenvironment (TME) features and their association with event-free survival (EFS) in patients with resectable NSCLC (R-NSCLC) from the phase 3 AEGEAN trial.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.8015